Neuralink's Human Brain-Implant Trial Begins

Elon Musk's brain-implant startup, Neuralink, has received approval from an independent review board to recruit patients for its first human trial. The company is seeking individuals with paralysis to test its experimental brain-computer interface (BCI) device in a six-year study. Neuralink aims to enable participants to control a computer cursor or keyboard using their thoughts. The company's previous animal testing has faced scrutiny, with allegations of unnecessary suffering and mishandling of biohazardous materials. The trial's details, including the number of participants and location, have not been disclosed. If successful, it could still take decades before the device is approved for wider use.